Carcinoembryonic Antigen, Fluid
0020742
Ordering Recommendation
 
Mnemonic
CEA FL
Methodology
Quantitative Electrochemiluminescent Immunoassay
Performed
Sun-Sat
Reported
Within 24 hours  
New York DOH Approval Status
This test is New York DOH approved.
Submit With Order
Specimen Required
Patient Preparation
  
Collect
Body fluid.  
Specimen Preparation
Transfer 1 mL body fluid to an ARUP Standard Transport Tube. (Min: 0.5 mL)  
Storage/Transport Temperature
Refrigerated.  
Unacceptable Conditions
Breast milk and salivary fluid. Specimens too viscous to be aspirated by instrument.  
Remarks
Indicate a source on test request form.  
Stability
Ambient: 8 hours; Refrigerated: 1 week; Frozen: 6 months  
Reference Interval
A reference interval has not been established for body fluid specimens.  
Interpretive Data
The Roche CEA electrochemiluminescent immunoassay is used. Results obtained with different assay methods or kits cannot be used interchangeably. Measurements of CEA have been shown to be clinically relevant in the management of patients with colorectal, breast, lung, prostatic, pancreatic, and ovarian carcinomas. Smokers may have slightly elevated levels of CEA. The CEA assay value, regardless of level, should not be interpreted as evidence for the presence or absence of malignant disease and is not recommended for use as a screening procedure to detect the presence of cancer in the general population. This test is FDA cleared but is not labeled for use with body fluids.

See Compliance Statement B: www.aruplab.com/CS  
Note
 
CPT Code(s)
82378
Components
Component Test Code*Component Chart Name
0020743Carcinoembryonic Antigen, Fluid
0020777Source, Fluid
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
  • Carcinoembryonic Antigen, fluid
  • CEA